A phase II, randomized, double-blind, placebo-controlled, cross-over, multi-centre study of the pharmacokinetics and tolerability of 3 different doses of ARD-0403 [testosterone] in testosterone deficient men
Latest Information Update: 12 Feb 2008
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Pharmacokinetics
- Sponsors Ardana plc
- 12 Feb 2008 New trial record.